drugset / Trial / NCT05134363
Dexmedetomidine for Prophylaxis Against PONV in Highly Susceptible Patients.
RandomizedParallel-groupSingle-blindPrevention
Summary
The study aims to compare between two bolus doses of dexmedetomidine in preventing PONV in highly susceptible patients.
Timeline
- Start
- 2021-08-11
- Primary completion
- 2023-06-20
- Completion
- 2023-06-20
Publications
- Background Apfel CC, Laara E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology. 1999 Sep;91(3):693-700. doi: 10.1097/00000542-199909000-00022.
- Results Kim SH, Oh YJ, Park BW, Sim J, Choi YS. Effects of single-dose dexmedetomidine on the quality of recovery after modified radical mastectomy: a randomised controlled trial. Minerva Anestesiol. 2013 Nov;79(11):1248-58. Epub 2013 May 23.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 0.5 ug/kg | — |
| Comparator | Dexmedetomidine | Other / unclassified | 0.75 ug/kg | — |
Indications
No indication recorded.